Apart from its role as a regulator of bone metabolism, osteoprotegerin has recently emerged as a significant factor in in the pathogenesis of atherosclerosis and cardiovascular diseases (182, 183), amplifying the adverse effects of inflammation and several traditional risk factors such as hyperlipidemia, type 2 diabetes, and hypertension (184). Here, TNFRSF11B is linked to cardiovascular disorder.